2021-03-31-accounts - Mast Cell Action

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

DocuSign Envelope ID: D52B69BD-4EB6-461D-961E-279C7BD29853


Trustees' Annual Report					for theperiod
From	Period start date			To	Period end date
	Day 01	Month 04	Year 2020		Day 31	Month 03	Year 2021

Section A Reference and administration details

Charity name Mast Cell Action Other names charity is known by Registered charity number (if any) 1164917 Charity's principal address Mast Cell Action 6 Willes Terrace Leamington Spa Postcode CV31 1DL

Names of the charity trustees who manage the charity

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19	Trustee name	Office (if any)	Dates acted if not for whole year	Name of person (or body) entitled to appoint trustee(if any)
	Gawain Paling			Trustee of the CIO at a properly convened meeting of the charitytrustees
	Ruth Slater			Trustee of the CIO at a properly convened meeting of the charitytrustees
	Chris Wood			Trustee of the CIO at a properly convened meeting of the charitytrustees
	George Hughes			Trustee of the CIO at a properly convened meeting of the charitytrustees

TAR

March 2012

DocuSign Envelope ID: D52B69BD-4EB6-461D-961E-279C7BD29853

Names of the trustees for the charity, if any, (for example, any custodian trustees)

Name	Dates acted if not for whole year
N/A

Names and addresses of advisers (Optional information)

Type of adviser Name Address

Name of chief executive or names of senior staff members (Optional information)

Section B Structure, governance and management

Description of the charity’s trusts

Type of governing document

Constitution

(eg. trust deed, constitution)

Charitable Incorporated Association How the charity is constituted

(eg. trust, association, company)

Trustee selection methods

Appointed at Trustees at meeting

(eg. appointed by, elected by)

Additional governance issues (Optional information)

You may choose to include additional information, where relevant, about:

Trustees receive a copy of the constitution and the trustees responsibilities.

policies and procedures adopted for the induction and training of trustees;
the charity’s organisational structure and any wider network with which the charity works;
relationship with any related parties;
trustees’ consideration of major risks and the system and procedures to manage them.

Section C Objectives and activities

TAR

March 2012

DocuSign Envelope ID: D52B69BD-4EB6-461D-961E-279C7BD29853

Summary of the objects of the charity set out in its governing document Summary of the main activities undertaken for the public benefit in relation to these objects (include within this section the statutory declaration that trustees have had regard to the guidance issued by the Charity Commission on public benefit)	To lobby for universal awareness, diagnosis and treatment of MCAS. To provide support for MCAS patients and their families. To support doctors and researchers with an interest in MCAS. To persuade the medical community that, by recognising Mast Cell Activation Syndrome, there will be a huge opportunity for the much more effective use of resources within the medical system. To bring the Mast Cell Activation Syndrome patient community together and create a cohesive voice.
	The main activities carried out in the financial year were: Collaborated with medical professionals to develop a children’s storybook to support families with discussion around MCAS and associated feelings. Did a charity raffle Supported our stake holders remotely through the pandemic Attended (virtually) an immunology conference. Improved awareness of MCAS and supported MCAS sufferers through our online resources. Brought on additional Volunteers. Improved our online infrastructure to better make resources available to our stakeholders.

Summary of the objects of
the charity set out in its
governing document
Summary of the main
activities undertaken for the
public benefit in relation to
these objects (include
within this section the
statutory declaration that
trustees have had regard to
the guidance issued by the
Charity Commission on
public benefit)

To lobby for universal awareness, diagnosis and treatment of MCAS.
To provide support for MCAS patients and their families.
To support doctors and researchers with an interest in MCAS.
To persuade the medical community that, by recognising Mast Cell
Activation Syndrome, there will be a huge opportunity for the much
more effective use of resources within the medical system.
To bring the Mast Cell Activation Syndrome patient community
together and create a cohesive voice.

The main activities carried out in the financial year were:
Collaborated with medical professionals to develop a children’s
storybook to support families with discussion around MCAS and
associated feelings.
Did a charity raffle
Supported our stake holders remotely through the pandemic
Attended (virtually) an immunology conference.
Improved awareness of MCAS and supported MCAS sufferers
through our online resources.
Brought on additional Volunteers.
Improved our online infrastructure to better make resources available
to our stakeholders.

Additional details of objectives and activities (Optional information)

You may choose to include further statements, where relevant, about:

policy on grantmaking;
policy programme related investment;
contribution made by volunteers.

TAR

March 2012

DocuSign Envelope ID: D52B69BD-4EB6-461D-961E-279C7BD29853

Section D Achievements and performance

Created a new series of marketing leaflets on MCAS Summary of the main Engaged with many doctors at conferences, raised awareness of the condition. achievements of the charity Supported MCAS sufferers during the year Produced a film through ITN to raise awareness of MCAS which was shown at the BSACI conference.

Created a series of wellbeing resources to support the MCAS community. Continued to build and support the patient community through our social media groups.

Supported the community by writing to supermarket chains to advocate for the need of specific products which are essential to those living with MCAS – such as free-from foods, bottled water and specific brands of some products.

Supported the community with medication supply issues due to covid by sourcing and sharing accurate and up-to date information.

Developed supportive resources to share through social media.

TAR

March 2012

DocuSign Envelope ID: D52B69BD-4EB6-461D-961E-279C7BD29853

Section E Financial review

Brief statement of the

The Charity has cash reserves held in a current account with a high street bank.

charity’s policy on reserves

Details of any funds materially in deficit

Further financial review details (Optional information)

You may choose to include additional information, where relevant about:

the charity’s principal sources of funds (including any fundraising);

Fundraising is from the general public from either specific events or ad hoc donations.

Almost all our expenditure is associated with attending medical conferences and the production of materials to help patients, raise awareness and educate doctors.

how expenditure has supported the key objectives of the charity;
investment policy and objectives including any ethical investment policy adopted.

Section F Other optional information

Section G Declaration

The trustees declare that they have approved the trustees’ report above.

Signed on behalf of the charity’s trustees

Signature(s) Gawain Paling Full name(s) George Hughes Position (eg Secretary, Chair, Treasurer Trustee etc) Date 27/01/2022

TAR

March 2012

DocuSign Envelope ID: D52B69BD-4EB6-461D-961E-279C7BD29853

Charity Name Mast Cell Action	Charity Name Mast Cell Action	Charity Name Mast Cell Action	No (if any) 1164917
Receipts andpayments accounts
For the period from	Period start date 4/1/2020	To	Period end date 3/31/2021

CC16a

Section A Receipts and payments	Section A Receipts and payments
A1 Receipts	Unrestricted funds to the nearest £	Restricted funds to the nearest £	Endowment funds to the nearest £	Total funds to the nearest £	Last year to the nearest £
Donations	20,113	-	-	20,113	-
*Sub total*(Gross income for AR)	20,113	-	-	20,113	-

A2 Asset and investment sales, (see table).
	-
	-				-
*Sub total*	-				-
*Total receipts*
	20,113				-

A3 Payments
Telephone and internet	944			944
Cost of FundraisingEvents	8,655			8,655
Print, Postage Stationary and Computer	6,212			6,212
Travel	59			59
Attendance at conferences and events	592			592
Rent/Hire of Rooms	854			854
Consulting	7,973			7,973
				-
		-	-	-	-
		-	-	-	-
		-	-	-	-
		-	-	-	-
**Sub total **	25,289.31	-	-	25,289	-

A4 Asset and investment purchases, (see table)
	-
	-
**Sub total **	-				-
*Total payments* *Net of receipts/(payments)* A5 Transfers between funds A6 Cash funds last year end *Cash funds this year end*
					-

	- 5,177	-	-	- 5,177	-
	-	-	-	-	-
	26,529	-	-	26,529	-
	21,352	-	-	21,352	-

CCXX R1 accounts (SS)

1/27/2022

DocuSign Envelope ID: D52B69BD-4EB6-461D-961E-279C7BD29853

Section B Statement of assets and liabilities at the end of the period

(agree balances with receipts and payments account(s)) Details *Total cash funds* Details	Unrestricted funds to nearest £ - - - - Agreement Error Unrestricted funds to nearest £	Restricted funds to nearest £ - - - - OK Restricted funds to nearest £	Endowment funds to nearest £
			-
			-
			-
			-
			OK
			Endowment funds to nearest £
	-	-	-
	-	-	-
	-	-	-
	-	-	-
	-	-	-
	-	-	-
Details	Fund to which asset belongs	Cost (optional)	Current value (optional)
		-	-
		-	-
		-	-
		-	-
		-	-
Details	Fund to which asset belongs	Cost (optional)	Current value (optional)
		-	-
		-	-
		-	-
		-	-
		-	-
		-	-
		-	-
		-	-
		-	-
Details	Fund to which liability relates	Amount due (optional)	When due (optional)
		-
		-
		-
		-
		-
Signature	Print Name George Hughes Gawain Paling
			Date of approval
			1/27/2022
			1/27/2022

CCXX R2 accounts (SS)

1/27/2022